Prediction of lithium response using m-chlorophenylpiperazine challenge test: A preliminary finding

International Clinical Psychopharmacology

Volumn 15, Issue 1, 2000, Pages 39-42

  Terao, Takeshi ^a   Nakamura, Jun ^a   Yoshimura, Reiji ^a   Ohmori, Osamu ^a   Takahashi, Norito ^a   Shinkai, Takahiro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Lithium; Meta chlorophenylpiperazine; Neuroendocrine challenge test; Response prediction

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; LITHIUM; SEROTONIN AGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; MALE; NEUROPHARMACOLOGY; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; SEROTONINERGIC NERVE CELL;

EID: 0033970738     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015010-00006     Document Type: Article

References (6)

1. Cowen PJ, McCance SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL (1991) Lithium in tricyclic-resistant depression: correlation of increased brain 5-HT function with clinical outcome. Br J Psychiatry 159:341-346.
2. Kahn RS, Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139-1166.
3. Marini JL (1980) Predicting lithium responders and non-responders: physiological indicators. In: Handbook of Lithium Therapy (Johnson FN, ed.), Lancaster: MTP Press Limited, pp. 118-125.
4. Price LH, Charney DS, Delgado PL, Heninger GR (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100:3-12.
5. 3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers. Biol Psychiatry 36:309-316.
6. Terao T, Yoshimura R, Ohmori O, Takano T, Takahashi N, Iwata N, et al. (1997) Effect of serum cholesterol levels on meta-chrolophenylpipearazine-evoked neuroendocrine responses in healthy subjects. Biol Psychiatry 41:974-978.